Advanced in COVID-19

Jorg J. Vehreschild

Frankfurt Am Main, HE, DE 
Advanced in COVID-19
Frankfurt Am Main, HE, DE 
OverviewLocationsClinical Research

Overview

Jorg Vehreschild practices in Frankfurt Am Main, Germany. Vehreschild is rated as an Advanced expert by MediFind in the treatment of COVID-19. Their top areas of expertise are Mucormycosis, Aspergillosis, Agranulocytosis, Severe Acute Respiratory Syndrome (SARS), and Bone Marrow Transplant.

Their clinical research consists of co-authoring 191 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 28 articles in the study of COVID-19.

Locations

Frankfurt Am Main, HE, Germany
Other Locations
Koeln, NW, Germany
Braunschweig, NI, Germany
Aachen, NW, Germany
Munich, BY, Germany
Hamburg, HH, Germany
Berlin, BE, Germany
Bad Salzuflen, NW, Germany
Duesseldorf, NW, Germany
Bonn, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patients Lacking Suitable Alternative Treatment Options
Enrollment Status: Completed
Publish Date: July 10, 2024
Intervention Type: Drug
Study Phase: Phase 2
Controling Intestinal Colonization of High Risk Patients With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae (ESBL-E) - A Randomized Trial (CLEAR)
Controling Intestinal Colonization of High Risk Patients With Extended Spectrum ß-Lactamase Producing Enterobacteriaceae (ESBL-E) - A Randomized Trial (CLEAR)
Enrollment Status: Terminated
Publish Date: May 08, 2017
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

191 Total Publications

Performance of Contradiction Rule Implementations in Health Data for Efficient Data Quality Assessments.
Performance of Contradiction Rule Implementations in Health Data for Efficient Data Quality Assessments.
Journal: Studies in health technology and informatics
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Vehreschild's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile